---
created: 2025-04-13
updated: 2025-04-13T10:51
id: DV^gc<Cs[M
specialty: gastro
specialty_id: 20
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/firstaid::02-immunology::04-immunosuppressants::03-recombinant-cytokines-&-clinical-uses
  - source/ak-step1-v11::
  - theme/firstaid::02-immunology::04-immunosuppressants::03-recombinant-cytokines-&-clinical-uses::immunotherapy::ifn-a
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::07-immunology
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::01-immunology::09-interferons-alpha,-beta,-&-gamma
  - source/ak-step1-v11::
  - theme/pixorize::01-immunology::07-leukemias-&-lymphomas::05-hcl
  - source/ak-step1-v11::
  - theme/sketchypharm::08-antineoplastics::04-immunology::01-interferon-a,-b,-y
  - source/ak-step1-v11::
  - theme/uworld::10000-99999::11000-11999::11750
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::gi::pharm"
type: flashcard
---

# Question
Interferon **alpha** may be used in the treatment of neoplasms, including **Hairy cell::indolent B-cell neoplasm in middle-aged men** leukemia and malignant **melanoma::skin cancer**   * Bonus: What are the main pathological findings?

---

# Answer
Confirmatory dx = flow cytometry, which has replaced tartrate-resistant acid phosphatase (TRAP) activity testing